Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

Foren & Soziale Netzwerke zur GSK ADR Aktie

 >GSK ADR Aktienkurs 
34.6 EUR    +0.0%    (Tradegate)
Ask: 34.4 EUR / 440 Stück
Bid: 34.2 EUR / 440 Stück
Tagesumsatz: 29 Stück
Realtime Kurs von 8 bis 22 Uhr!
GSK ADR Aktie über LYNX handeln
>GSK ADR Performance
1 Woche: +4,2%
1 Monat: +10,2%
3 Monate: +0,3%
6 Monate: -1,4%
1 Jahr: -8,0%
laufendes Jahr: +5,5%
>GSK ADR Aktie
Name:  GSK PLC SP. ADR/2 NEW
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US37733W2044 / A3DMHS
Symbol/ Ticker:  GS70 (Frankfurt) / GSK (NYSE)
Kürzel:  FRA:GS70, ETR:GS70, GS70:GR, NYSE:GSK
Index:  -
Webseite:  https://www.gsk.com/
Profil:  GSK plc Sponsored ADR represents the American Depo..
>Volltext..
Marktkapitalisierung:  68438.2 Mio. EUR
Unternehmenswert:  84019.21 Mio. EUR
Umsatz:  37061.44 Mio. EUR
EBITDA:  10808.76 Mio. EUR
Nettogewinn:  4010.66 Mio. EUR
Gewinn je Aktie:  0.98 EUR
Schulden:  20333.35 Mio. EUR
Liquide Mittel:  4216.88 Mio. EUR
Operativer Cashflow:  8527.49 Mio. EUR
Bargeldquote:  0.18
Umsatzwachstum:  9.22%
Gewinnwachstum:  -7.84%
Dividende je Aktie:  1.41 EUR
Dividendenrendite:  4.15%
Dividendenschätzung:  4.33%
Div. Historie:  15.08.25 - 0.36565557€
16.05.25 - 0.37134048€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  GSK ADR, GSK, GLAXOSMITHKLINE, GLAXO
Letzte Datenerhebung:  23.08.25
>GSK ADR Kennzahlen
Aktien/ Unternehmen:
Aktien: 4029.67 Mio. St.
Frei handelbar: 96.39%
Rückkaufquote: 1.36%
Mitarbeiter: 68629
Umsatz/Mitarb.: 0.49 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 9.81%
Bewertung:
KGV: 17.48
KGV lG: 9.1
KUV: 1.93
KBV: 3.97
PEG-Ratio: -
EV/EBITDA: 7.77
Rentabilität:
Bruttomarge: 71.69%
Gewinnmarge: 10.82%
Operative Marge: 17.22%
Managementeffizenz:
Gesamtkaprendite: 5.84%
Eigenkaprendite: 23.47%
 >GSK ADR Anleihen 
Es sind 6 Anleihen zur GSK ADR Aktie bekannt.
>GSK ADR Peer Group

Es sind 601 Aktien bekannt.
 
03.08.25 - 15:03
StockNews_com: buy GSK plc ADR (Sharewise)
 
Kursziel: -
14.04.25 - 17:24
4/14/25 - $gs - A buy (TradingView)
 
4/14/25 :: VROCKSTAR :: NYSE:GS A buy - 1.5x book w/ mid teens ROEs. - 11x PE - great result - financials will do well in this environment - not a tariff punching bag - all the financial services should supplement IPO/ IB issues in the ST - trying to keep cash high - but you could get 3% yield on a 2 week expiry at $500 stirke - or cash secured puts for about 2% yield on the week $500 strike - but for now i'm just playing other stuff - though i'd like to dip buy this on the next sell off if/when bc i'd like to start growing financials exposure in my book this year (which i think does well in this environment) V
08.02.25 - 19:30
Weekly Breakout off consolidation: Feb 8, 2024 (TradingView)
 
I talk about many names that could be interesting investments for weeks to come.
07.02.25 - 14:39
AI_StockPirate: buy GSK plc ADR (Sharewise)
 
Kursziel: 38.5 €
28.01.25 - 11:57
Goldman Sachs. (TradingView)
 
https://www.tradingview.com/x/BLkEqQOd/ One last piece remaining in GS before a meaningful correction. That the max extension in time shown.
21.01.25 - 04:18
GS Testing Channel Resistance! Key Trade Setups for Tomorrow (TradingView)
 
Analysis: Goldman Sachs (GS) is approaching the upper boundary of its rising channel near $628, suggesting a potential for either a breakout or a rejection. The stock has shown strong upward momentum, rallying from the $556 support level. The MACD remains bullish, although the histogram is flattening, indicating slowing momentum. Meanwhile, the Stochastic RSI is nearing overbought levels, hinting at a possible pullback or consolidation. Volume remains consistent, supporting the uptrend, but traders should watch closely as the stock approaches a critical resistance zone. Key Levels to Watch: * Resistance Levels: * $628: Immediate resistance at the current price level, aligning with the upper channel boundary. * $630-$635: Extended resistance zone if momentum continues. * Support Levels: * $620: Near-term support level within the rising channel. * $600: Key psychological and technical support. * $556-$560: Strong downside support, aligning with previous lows. GEX Insights: https://www.t
05.01.25 - 15:03
StockNews_com: buy GSK plc ADR (Sharewise)
 
Kursziel: -
28.12.24 - 15:03
StockNews_com: buy GSK plc ADR (Sharewise)
 
Kursziel: -
18.12.24 - 17:15
$GS flagging long after highs (TradingView)
 
Two $585c came in for the beginning of the year for about a million dollars so I had to check the chart out. Will start a position. WSL
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Politiker verschweigt oft auch das, was er nicht weiß. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!